Dr Ingrid Espinoza
Associate Editor: Dr Ingrid Espinoza
Dr. Espinoza is an Assistant Professor in the Department of Preventive Medicine, and Biochemistry, and a member of the Cancer Institute at the University of Mississippi Medical Center (UMMC). She has a Ph.D. in Biomedical Sciences and is a Clinical Research Certified investigator with expertise in cancer. Dr. Espinoza obtained her Ph.D. in the Faculty of Medicine at the University of Chile. In 2004, she moved to U.S.A. to complete her postdoctoral training at Evanston Northwestern Healthcare (ENH), Northwestern University, Evanston, IL. Since then, her research have been focus in: i). Identification of molecular biomarkers involved in drug resistance in tumors including breast, colorectal, and prostate, and ii). Development of combinatorial-targeted therapies to revert treatment resistance. In 2008, she moved to Mayo Clinic in Rochester, MN, as a Professional Associate in Research. Here she continued her work in breast and pancreatic cancer. Currently, her research focused in the identification and validation of molecular markers for radiation and drug resistance in prostate and colorectal cancer; the impact of hypoxia on cancer progression; and the development of new combinatorial therapies to revert treatment resistance. Dr. Espinoza has accomplished many publications, including research articles, reviews, and book chapters. She serves as an ad hoc reviewer for several international journals in biomedical science. She is also member of several international scientific and clinical societies.